Understanding the molecular causes and risks of kidney and related diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the molecular mechanisms that contribute to the development, progression, and complications of kidney diseases, including acute kidney injury and chronic kidney disease. By collecting biological samples from patients at risk or diagnosed with kidney-related conditions, the study seeks to identify genetic and environmental factors that influence disease outcomes. The research will also explore the impact of treatments and complications associated with solid-organ transplantation. Ultimately, the goal is to enhance risk stratification and improve patient management in nephrology.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients (\> 18 year of age) with kidney disease or at risk to develop a kidney disease,
* Patients followed by a practitioner of the Department of Nephrology and Organ Transplantations of the University Hospital of Toulouse (France)

Exclusion Criteria:

* consent deny
* inability of the patient or its family to give consent.

Where it's running

• Rangueil University Hospital
  Toulouse, France Recruiting

Study contacts

• Principal investigator: Stanislas Faguer, MD, PhD — University Hospital, Toulouse
• Study coordinator: Stanislas Faguer, MD, PhD
• Email: faguer.s@chu-toulouse.fr
• Phone: 561322475

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes

  This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07868666

• Reducing surgical bleeding in adults with advanced or acute kidney disease

  This trial will test whether giving tranexamic acid or desmopressin before noncardiac surgery reduces bleeding in adults with advanced chronic kidney disease or recent acute kidney injury, including those on dialysis.

  Recruiting at 2 sites Phase 3 Hamilton Health Sciences Corporation · London, Ontario and 2 other locations · NCT06337838

• Evaluating kidney and blood pressure outcomes in childhood cancer survivors

  This study is trying to see how common kidney problems and high blood pressure are in childhood cancer survivors a few years after their treatment.

  Recruiting The Hospital for Sick Children · Toronto, Ontario · NCT06153147

• Using advanced imaging to analyze kidney biopsies for better diagnosis of kidney conditions

  This study is testing a new imaging technique to see if it can help doctors diagnose kidney problems more accurately and quickly in adults who need a biopsy.

  Recruiting Centre Hospitalier William Morey - Chalon sur Saône · Chalon-sur-Saône, Saône-et-Loire · NCT05728216

• Goal-directed blood pressure, fluid, and urine management to prevent kidney injury after kidney removal

  This will try a targeted plan of fluids, medicines, and forced urine output during surgery to see if it reduces acute kidney injury in adults having a radical nephrectomy or nephroureterectomy.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality · NCT05149196

• Remote Ischemic Preconditioning at Different Times After Heart Valve Surgery

  This study tests whether applying brief, controlled blood-flow restrictions to a limb at different times after heart valve surgery can help protect organs and reduce complications like kidney injury.

  Recruiting Fujian Medical University Union Hospital · Fuzhou, Fujian · NCT07888634

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.